Filing Details
- Accession Number:
- 0001209191-18-048051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-22 19:03:05
- Reporting Period:
- 2018-08-21
- Accepted Time:
- 2018-08-22 19:03:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 16040 | Cabot Corp | CBT | Miscellaneous Chemical Products (2890) | 042271897 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1626212 | S. Nicholas Cross | C/O Cabot Corporation Two Seaport Lane, Suite 1300 Boston MA 02210 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-21 | 6,000 | $65.87 | 48,597 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-21 | 10,000 | $46.03 | 58,597 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-21 | 10,000 | $65.86 | 48,597 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-08-21 | 10,000 | $0.00 | 17,857 | $46.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,857 | 2017-11-14 | 2024-11-13 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.80 to $65.94, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.60 to $66.03, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- 17,857 shares remained subject to the option. The option vested over a three year period as follows: 30% on November 14, 2015, 30% on November 14, 2016, and 40% on November 14, 2017.
Billionaire Hedge Funds
